{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:47:03Z","timestamp":1758808023084,"version":"3.44.0"},"reference-count":197,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Clinics of North America"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.ucl.2013.07.003","type":"journal-article","created":{"date-parts":[[2013,9,3]],"date-time":"2013-09-03T18:46:25Z","timestamp":1378233985000},"page":"521-543","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Office-Based Management of Impotence and Peyronie\u2019s Disease"],"prefix":"10.1016","volume":"40","author":[{"given":"Ashley H.","family":"Tapscott","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence S.","family":"Hakim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ucl.2013.07.003_bib1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/sj.ijir.3900396","article-title":"Definition and classification of erectile dysfunction: report of the nomenclature committee of the International Society of Impotence Research","volume":"11","author":"Lizza","year":"1999","journal-title":"Int J Impot Res"},{"issue":"1","key":"10.1016\/j.ucl.2013.07.003_bib2","first-page":"54","article-title":"Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study","volume":"151","author":"Feldman","year":"1994","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ucl.2013.07.003_bib3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/sj.ijir.3900269","article-title":"On life satisfaction in male erectile dysfunction","volume":"9","author":"Fugl-Meyer","year":"1997","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.ucl.2013.07.003_bib4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2165\/00019053-200220020-00004","article-title":"Health-related quality of life in a UK-based population of men with erectile dysfunction","volume":"20","author":"Guest","year":"2002","journal-title":"Pharmacoeconomics"},{"issue":"Suppl 1","key":"10.1016\/j.ucl.2013.07.003_bib5","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1038\/sj.ijir.3900487","article-title":"The epidemiology of erectile dysfunction: results from the National Health and Social Life Survey","volume":"11","author":"Laumann","year":"1999","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.ucl.2013.07.003_bib6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1525-1497.1998.00050.x","article-title":"Health-related quality of life in men with erectile dysfunction","volume":"13","author":"Litwin","year":"1998","journal-title":"J\u00a0Gen Intern Med"},{"issue":"24","key":"10.1016\/j.ucl.2013.07.003_bib7","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1056\/NEJM200006153422407","article-title":"Erectile dysfunction","volume":"342","author":"Lue","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ucl.2013.07.003_bib8","series-title":"Sexual medicine: sexual dysfunctions in men and women","first-page":"39","article-title":"Definitions, classification, and epidemiology of sexual dysfunction","author":"Lewis","year":"2004"},{"issue":"4","key":"10.1016\/j.ucl.2013.07.003_bib9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/sj.ijir.3900542","article-title":"Measurement of erectile dysfunction in population-based studies: the use of a single question self-assessment in the Massachusetts Male Aging Study","volume":"12","author":"Derby","year":"2000","journal-title":"Int J Impot Res"},{"issue":"5","key":"10.1016\/j.ucl.2013.07.003_bib10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0895-4356(94)90292-5","article-title":"Construction of a surrogate variable for impotence in the Massachusetts Male Aging Study","volume":"47","author":"Feldman","year":"1994","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.ucl.2013.07.003_bib11","first-page":"460","article-title":"Incidence of erectile dysfunction in men 40\u201369 years old: longitudinal results from the Massachusetts Male Aging Study","volume":"163","author":"Johannes","year":"2000","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ucl.2013.07.003_bib12","first-page":"150","article-title":"The multinational men\u2019s attitudes to life events and sexuality (MALES) study phase II: understanding PDE5 inhibitor treatment seeking patterns among men with erectile dysfunction","volume":"1","author":"Fisher","year":"2004","journal-title":"J\u00a0Sex Med"},{"issue":"6","key":"10.1016\/j.ucl.2013.07.003_bib13","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/sj.ijir.3900622","article-title":"Epidemiology of erectile dysfunction: results of the Cologne Male Survey","volume":"12","author":"Braun","year":"2000","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.ucl.2013.07.003_bib14","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(05)66911-5","article-title":"Men in Australia, Telephone Survey (MATeS) I: a national survey of the reproductive health and concerns of middle aged and older Australian men","volume":"366","author":"Holden","year":"2005","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ucl.2013.07.003_bib15","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1046\/j.1532-5415.2001.49088.x","article-title":"Correlates for erectile and ejaculatory dysfunction in older Dutch men: a community-based study","volume":"49","author":"Blanker","year":"2001","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"6","key":"10.1016\/j.ucl.2013.07.003_bib16","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.eururo.2003.08.015","article-title":"Lower urinary tract systems and male sexual dysfunction: the multinational survey of the aging male (MSAM-7)","volume":"44","author":"Rosen","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.ucl.2013.07.003_bib17","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.eururo.2004.12.013","article-title":"Sexual dysfunction and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH)","volume":"47","author":"Rosen","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.ucl.2013.07.003_bib18","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/sj.ijir.3901197","article-title":"Quality of life, mood, and sexual function: a path analytic model of treatment effects in men with erectile dysfunction and depressive symptoms","volume":"16","author":"Rosen","year":"2004","journal-title":"Int J Impot Res"},{"issue":"4","key":"10.1016\/j.ucl.2013.07.003_bib19","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1006\/pmed.2000.0643","article-title":"Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts Male Aging Study","volume":"30","author":"Feldman","year":"2000","journal-title":"Prev Med"},{"key":"10.1016\/j.ucl.2013.07.003_bib20","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.jacc.2003.11.041","article-title":"Heart disease risk factors predict erectile dysfunction 25 years later. The Rancho Bernardo Study","volume":"43","author":"Fung","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ucl.2013.07.003_bib21","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1742-1241.1999.tb11747.x","article-title":"Erectile dysfunction and cardiovascular disease","volume":"53","author":"Jackson","year":"1999","journal-title":"Int J Clin Pract"},{"issue":"2","key":"10.1016\/j.ucl.2013.07.003_bib22","first-page":"569","article-title":"Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfuncion ErectilMasculina Study","volume":"166","author":"Martin-Morales","year":"2001","journal-title":"J\u00a0Urol"},{"issue":"Suppl 4","key":"10.1016\/j.ucl.2013.07.003_bib23","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1038\/sj.ijir.3900567","article-title":"The worldwide prevalence and epidemiology of erectile dysfunction","volume":"12","author":"McKinlay","year":"2000","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.ucl.2013.07.003_bib24","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0090-4295(98)00292-1","article-title":"Increased incidence of depressive symptoms in men with erectile dysfunction","volume":"52","author":"Shabsigh","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.ucl.2013.07.003_bib25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/0003-4819-139-3-200308050-00005","article-title":"Sexual function in men older than 50 years of age: results from the Health Professionals Follow-Up Study","volume":"139","author":"Bacon","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ucl.2013.07.003_bib26","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/sj.ijir.3901333","article-title":"Obesity, the metabolic syndrome and sexual dysfunction","volume":"17","author":"Esposito","year":"2005","journal-title":"Int J Impot Res"},{"issue":"9","key":"10.1016\/j.ucl.2013.07.003_bib27","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1358\/dnp.2001.14.9.858411","article-title":"Directions in urological research and drug therapies","volume":"4","author":"Gopalakrishnan","year":"2001","journal-title":"Drug News Perspect"},{"key":"10.1016\/j.ucl.2013.07.003_bib28","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0090-4295(97)00238-0","article-title":"The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction","volume":"49","author":"Rosen","year":"1997","journal-title":"Urology"},{"issue":"Suppl 4","key":"10.1016\/j.ucl.2013.07.003_bib29","first-page":"S3","article-title":"The influence of personality traits on the erectile response to intracavernosal PGE-1 injections","volume":"14","author":"Mas","year":"2002","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.ucl.2013.07.003_bib30","first-page":"88","article-title":"The state of theory in sex therapy","volume":"35","author":"Wiederman","year":"1998","journal-title":"J\u00a0Sex Res"},{"key":"10.1016\/j.ucl.2013.07.003_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2002-25177","article-title":"Control beliefs and\u00a0anxiety in heterosexual men with erectile disorder: an empirical study","volume":"15","author":"Feil","year":"2002","journal-title":"Zeitschrift f\u00fcr Sexualforschung"},{"year":"1992","series-title":"Sexual life, a clinicians guide","author":"Levine","key":"10.1016\/j.ucl.2013.07.003_bib32"},{"key":"10.1016\/j.ucl.2013.07.003_bib33","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/00006842-199807000-00011","article-title":"The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts Male Aging Study","volume":"60","author":"Araujo","year":"1998","journal-title":"Psychosom Med"},{"key":"10.1016\/j.ucl.2013.07.003_bib34","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1037\/0022-006X.54.2.140","article-title":"Causes of sexual dysfunction: the role of anxiety and cognitive interference","volume":"54","author":"Barlow","year":"1986","journal-title":"J\u00a0Consult Clin Psychol"},{"issue":"Suppl 1","key":"10.1016\/j.ucl.2013.07.003_bib35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sj.ijir.3900799","article-title":"When an erection alone is not enough: biopsychosocial obstacles to lovemaking","volume":"14","author":"Althof","year":"2002","journal-title":"Int J Impot Res"},{"year":"2001","series-title":"Sexual dysfunction: a guide for assessment and treatment","author":"Wincze","key":"10.1016\/j.ucl.2013.07.003_bib36"},{"issue":"5","key":"10.1016\/j.ucl.2013.07.003_bib37","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1023\/A:1024559906540","article-title":"Treatment outcome of brief couple therapy in psychogenic male erectile disorder","volume":"26","author":"Wylie","year":"1997","journal-title":"Arch Sex Behav"},{"key":"10.1016\/j.ucl.2013.07.003_bib38","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11920-001-0052-8","article-title":"The impact of the new sexual pharmaceuticals on sex therapy","volume":"3","author":"Perelman","year":"2001","journal-title":"Curr Psychiatry Rep"},{"issue":"2","key":"10.1016\/j.ucl.2013.07.003_bib39","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0094-0143(05)70139-7","article-title":"Neurologic erectile dysfunction","volume":"28","author":"Nehra","year":"2001","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.ucl.2013.07.003_bib40","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0090-4295(00)00614-2","article-title":"Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk?","volume":"56","author":"Derby","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.ucl.2013.07.003_bib41","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/sj.ijir.3901010","article-title":"Prevalence of erectile dysfunction and associated factors among men without concomitant diseases: a population study","volume":"15","author":"Nicolosi","year":"2003","journal-title":"Int J Impot Res"},{"issue":"5","key":"10.1016\/j.ucl.2013.07.003_bib42","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/00019052-200210000-00011","article-title":"Autonomic neuropathies","volume":"15","author":"Low","year":"2002","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.ucl.2013.07.003_bib43","first-page":"65","article-title":"Polyneuropathy in impotence","volume":"8","author":"Vardi","year":"1996","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.ucl.2013.07.003_bib44","series-title":"Erectile dysfunction","first-page":"591","article-title":"Neurological disorders: erectile and ejaculatory dysfunction","author":"Lundberg","year":"1999"},{"key":"10.1016\/j.ucl.2013.07.003_bib45","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00002826-199010000-00008","article-title":"Sexual function in Parkinson\u2019s disease","volume":"13","author":"Kaufman","year":"1990","journal-title":"Clin Neuropharmacol"},{"issue":"6","key":"10.1016\/j.ucl.2013.07.003_bib46","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/jnnp.53.6.480","article-title":"Sexual dysfunction in patients with Parkinson\u2019s disease and their partners","volume":"53","author":"Brown","year":"1990","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ucl.2013.07.003_bib47","first-page":"743","article-title":"Multiple sclerosis and the urologist","volume":"161","author":"Litwiller","year":"1999","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ucl.2013.07.003_bib48","first-page":"19","article-title":"Sexual dysfunction in stroke patients","volume":"67","author":"Monga","year":"1986","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.ucl.2013.07.003_bib49","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2340\/16501977198315155163","article-title":"Sexuality after stroke. Aspects of sexual function","volume":"15","author":"Sjogren","year":"1983","journal-title":"Scand J Rehabil Med"},{"key":"10.1016\/j.ucl.2013.07.003_bib50","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0022-3999(84)90026-6","article-title":"Sexual adjustment of men who have had strokes","volume":"28","author":"Hawton","year":"1984","journal-title":"J\u00a0Psychosom Res"},{"key":"10.1016\/j.ucl.2013.07.003_bib51","series-title":"Erectile dysfunction: issues in current pharmacotherapy","first-page":"141","article-title":"Androgens, sexual endocrinopathies and their treatment","author":"Morales","year":"1998"},{"key":"10.1016\/j.ucl.2013.07.003_bib52","series-title":"Sexual medicine: sexual dysfunctions in men and women","first-page":"345","article-title":"Endocrine aspects of male sexual dysfunction","author":"Morales","year":"2004"},{"key":"10.1016\/j.ucl.2013.07.003_bib53","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0378-5122(99)00075-4","article-title":"Andropause","volume":"35","author":"Vermeulen","year":"2000","journal-title":"Maturitas"},{"key":"10.1016\/j.ucl.2013.07.003_bib54","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1210\/jcem.87.2.8201","article-title":"Age trends in the levels of serum testosterone and other hormones in middle-aged men: longitudinal results of the Massachusetts Male Aging Study","volume":"87","author":"Feldman","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ucl.2013.07.003_bib55","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00345-002-0256-5","article-title":"The ageing penis","volume":"20","author":"Wespes","year":"2002","journal-title":"World J Urol"},{"key":"10.1016\/j.ucl.2013.07.003_bib56","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1210\/jcem-73-5-1016","article-title":"Age, disease and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study","volume":"73","author":"Gray","year":"1991","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"Suppl","key":"10.1016\/j.ucl.2013.07.003_bib57","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/S0025-6196(19)30641-X","article-title":"Treatment of endocrinologic male sexual dysfunction","volume":"75","author":"Nehra","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ucl.2013.07.003_bib58","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/BF01542116","article-title":"Changes in erectile responsiveness during androgen replacement therapy","volume":"12","author":"Bancroft","year":"1983","journal-title":"Arch Sex Behav"},{"key":"10.1016\/j.ucl.2013.07.003_bib59","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/0306-4530(95)00017-8","article-title":"The effects of testosterone replacement on nocturnal penile tumescence testing, rigidity and erectile response to visual erotic stimuli in hypogonadal men","volume":"20","author":"Carani","year":"1995","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"10.1016\/j.ucl.2013.07.003_bib60","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00059-003-2479-7","article-title":"The physiology of erectile dysfunction","volume":"28","author":"Russell","year":"2003","journal-title":"Herz"},{"key":"10.1016\/j.ucl.2013.07.003_bib61","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0008-6363(99)00135-2","article-title":"Nitric oxide and penile erection: is erectile dysfunction another manifestation of vascular disease?","volume":"43","author":"Sullivan","year":"1999","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ucl.2013.07.003_bib62","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF01541402","article-title":"Male sexual dysfunction associated with coronary artery disease","volume":"9","author":"Wabrek","year":"1990","journal-title":"Arch Sex Behav"},{"issue":"4","key":"10.1016\/j.ucl.2013.07.003_bib63","first-page":"197","article-title":"Some factors influencing quality of sexual life after myocardial infarction","volume":"5","author":"Sjogren","year":"1983","journal-title":"Int Rehabil Med"},{"issue":"6","key":"10.1016\/j.ucl.2013.07.003_bib64","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/pcad.2003.YPCAD13","article-title":"Smoking and endothelial function","volume":"45","author":"Puranik","year":"2003","journal-title":"Prog Cardiovasc Dis"},{"issue":"11","key":"10.1016\/j.ucl.2013.07.003_bib65","doi-asserted-by":"crossref","first-page":"891","DOI":"10.7326\/0003-4819-138-11-200306030-00010","article-title":"Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States","volume":"138","author":"Bazzano","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ucl.2013.07.003_bib66","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1006\/pmed.2001.0830","article-title":"The link between smoking and impotence: two decades of evidence","volume":"32","author":"Tengs","year":"2001","journal-title":"Prev Med"},{"issue":"4","key":"10.1016\/j.ucl.2013.07.003_bib67","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0094-0143(21)00690-X","article-title":"The epidemiology of erectile dysfunction","volume":"22","author":"Benet","year":"1995","journal-title":"Urol Clin North Am"},{"issue":"4","key":"10.1016\/j.ucl.2013.07.003_bib68","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1464-410X.2004.04991.x","article-title":"Mechanisms of vasculogenic erectile dysfunction after kidney transplantation","volume":"94","author":"Abdel-Hamid","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.ucl.2013.07.003_bib69","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1001\/jama.283.3.354","article-title":"Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study","volume":"283","author":"Stanford","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ucl.2013.07.003_bib70","first-page":"1929","article-title":"Factors predicting recovery of erections after radical prostatectomy","volume":"164","author":"Rabbani","year":"2000","journal-title":"J\u00a0Urol"},{"issue":"Suppl 4","key":"10.1016\/j.ucl.2013.07.003_bib71","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1038\/sj.ijir.3900577","article-title":"Medical and surgical advances in the radical prostatectomy patient","volume":"12","author":"Nehra","year":"2000","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.ucl.2013.07.003_bib72","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/jama.1984.03340310017012","article-title":"Radiation associated impotence: a clinical study of its mechanism","volume":"251","author":"Goldstein","year":"1984","journal-title":"JAMA"},{"issue":"2 Suppl 1","key":"10.1016\/j.ucl.2013.07.003_bib73","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0090-4295(02)01679-5","article-title":"Quality of life and sexuality of men with prostate cancer 3 years after cryosurgery","volume":"60","author":"Robinson","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.ucl.2013.07.003_bib74","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1046\/j.1464-4096.2001.01817.x","article-title":"Sexual function after various treatments for symptomatic benign prostatic hyperplasia","volume":"89","author":"Leliefeld","year":"2002","journal-title":"BJU Int"},{"key":"10.1016\/j.ucl.2013.07.003_bib75","series-title":"Sexual medicine: sexual dysfunctions in men and women","first-page":"175","article-title":"Clinical evaluation and symptom scales: sexual dysfunction assessment in men","author":"Rosen","year":"2004"},{"issue":"6","key":"10.1016\/j.ucl.2013.07.003_bib76","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0025-6196(11)62632-3","article-title":"Erectile dysfunction and cardiovascular disease","volume":"79","author":"Russell","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ucl.2013.07.003_bib77","series-title":"Sexual medicine: sexual dysfunctions in men and women","first-page":"207","article-title":"Clinical evaluation and symptom scales: sexual dysfunction assessment in men [annex I]","author":"Rosen","year":"2004"},{"issue":"4","key":"10.1016\/j.ucl.2013.07.003_bib78","first-page":"1425","article-title":"Pudendal nerve somatosensory evoked potentials in patients with voiding and\/or erectile dysfunction: correlating test results with clinical findings","volume":"156","author":"Klausner","year":"1996","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.ucl.2013.07.003_bib79","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1365-2605.2002.00314.x","article-title":"Penile pharmacotesting in diagnosing male erectile dysfunction: evidence for lack of accuracy and specificity","volume":"25","author":"Aversa","year":"2002","journal-title":"Int J Androl"},{"key":"10.1016\/j.ucl.2013.07.003_bib80","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0037-198X(05)80112-9","article-title":"Duplex Doppler ultrasonography: noninvasive assessment of penile anatomy and function","volume":"28","author":"Broderick","year":"1993","journal-title":"Semin Roentgenol"},{"key":"10.1016\/j.ucl.2013.07.003_bib81","series-title":"Color duplex sonography: principles and clinical application","first-page":"204","article-title":"Penile vessels: erectile dysfunction","author":"Landwehr","year":"1995"},{"key":"10.1016\/j.ucl.2013.07.003_bib82","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/sj.ijir.3901313","article-title":"A\u00a0prospective randomized study to optimize the dosage of trimix ingredients and compare its efficacy and safety with prostaglandin E1","volume":"17","author":"Seyam","year":"2005","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.ucl.2013.07.003_bib83","first-page":"61","article-title":"The combined intracavernous injection and stimulation test: diagnostic accuracy","volume":"148","author":"Donatucci","year":"1992","journal-title":"J\u00a0Urol"},{"issue":"3","key":"10.1016\/j.ucl.2013.07.003_bib84","first-page":"809","article-title":"Scoring correspondence in outcomes related to erectile dysfunction treatment on a 4-point scale (SCORE-4)","volume":"6","author":"Cappelleri","year":"2009","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.ucl.2013.07.003_bib85","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1007\/s00261-008-9463-x","article-title":"Erectile dysfunction: the role of penile Doppler ultrasound in diagnosis","volume":"34","author":"Halls","year":"2009","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.ucl.2013.07.003_bib86","first-page":"A30","article-title":"Dynamic color Doppler sonography in the evaluation of penile erectile disorders","volume":"6","author":"Lewis","year":"1994","journal-title":"Int J Impot Res"},{"issue":"4","key":"10.1016\/j.ucl.2013.07.003_bib87","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/sj.ijir.3900704","article-title":"The value of sildenafil as a mode of stimulation in pharmacopenile duplex ultrasonography","volume":"13","author":"Speel","year":"2001","journal-title":"Int J Impot Res"},{"issue":"1","key":"10.1016\/j.ucl.2013.07.003_bib88","first-page":"181","article-title":"A\u00a0new method for the evaluation of erectile dysfunction: sildenafil plus Doppler ultrasonography","volume":"66","author":"Arslan","year":"2001","journal-title":"J\u00a0Urol"},{"issue":"3","key":"10.1016\/j.ucl.2013.07.003_bib89","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1148\/radiol.2373041529","article-title":"Clinical and duplex US assessment of effects of sildenafil on cavernosal arteries of the penis: comparison with intracavernosal injection of vasoactive agent- initial experience","volume":"237","author":"Copel","year":"2005","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.ucl.2013.07.003_bib90","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000058446","article-title":"Is sildenafil citrate an alternative agent in the evaluation of penile vascular system with color Doppler ultrasound","volume":"68","author":"Erdogru","year":"2002","journal-title":"Urol Int"},{"issue":"2","key":"10.1016\/j.ucl.2013.07.003_bib91","doi-asserted-by":"crossref","first-page":"165","DOI":"10.47102\/annals-acadmedsg.V31N2p165","article-title":"Color duplex ultrasonography as a screening tool for venogenic erectile dysfunction","volume":"31","author":"Teh","year":"2002","journal-title":"Ann Acad Med Singapore"},{"issue":"7","key":"10.1016\/j.ucl.2013.07.003_bib92","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0009-9260(03)00112-0","article-title":"Color Doppler ultrasound of the penis","volume":"58","author":"Wilkins","year":"2003","journal-title":"Clin Radiol"},{"issue":"11","key":"10.1016\/j.ucl.2013.07.003_bib93","first-page":"1231","article-title":"Clinical studies for venogenic impotence with color Doppler ultrasonography- evaluation of resistance index of the cavernous artery","volume":"87","author":"Naroda","year":"1996","journal-title":"Nippon Hinyokika Gakkai Zasshi"},{"issue":"4","key":"10.1016\/j.ucl.2013.07.003_bib94","first-page":"187","article-title":"Penile nuclear magnetic resonance","volume":"66","author":"Bellorofonte","year":"1994","journal-title":"Arch Ital Urol Androl"},{"issue":"2","key":"10.1016\/j.ucl.2013.07.003_bib95","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0090-4295(00)00906-7","article-title":"Relationship between penile thermal sensory threshold- measurement and electrophysiologic tests to assess neurogenic impotence","volume":"57","author":"Lefaucheur","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.ucl.2013.07.003_bib96","first-page":"337","article-title":"Sur quelques obstacles qui s\u2019opposent a l\u2019ejaculation naturelle de la semence","volume":"1","author":"de la Peyronie","year":"1743","journal-title":"Mem Acad Royale Chir"},{"key":"10.1016\/j.ucl.2013.07.003_bib97","first-page":"2284","article-title":"An animal model of Peyronie\u2019s like condition associated with an increase of transforming growth factor beta mRNA and protein expression","volume":"158","author":"El-Sakka","year":"1997","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ucl.2013.07.003_bib98","first-page":"1391","article-title":"Peyronie\u2019s disease is associated with an increase in transforming growth factor-beta protein expression","volume":"158","author":"El-Sakka","year":"1997","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ucl.2013.07.003_bib99","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.ijir.3900874","article-title":"Peyronie\u2019s disease cell culture models: phenotypic, genotypic and functional analyses","volume":"14","author":"Mulhall","year":"2002","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.ucl.2013.07.003_bib100","first-page":"1330","article-title":"Peyronie\u2019s disease is associated with an HLA class II antigen, HLA-DQ5, implying an autoimmune etiology","volume":"156","author":"Nachtsheim","year":"1996","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ucl.2013.07.003_bib101","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0090-4295(97)00333-6","article-title":"Immunologic findings in Peyronie\u2019s disease: a controlled study","volume":"50","author":"Schiavino","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.ucl.2013.07.003_bib102","first-page":"1607","article-title":"Profibrotic role of myostatin in Peyronie\u2019s disease","volume":"5","author":"Cantini","year":"2008","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.ucl.2013.07.003_bib103","first-page":"1284","article-title":"IN-1130, a novel transforming growth factor-beta type I receptor kinase (activin receptor-like kinase 5) inhibitor, promotes regression of fibrotic plaque and corrects penile curvature in a rat model of Peyronie\u2019s disease","volume":"6","author":"Ryu","year":"2009","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.ucl.2013.07.003_bib104","series-title":"The history of urology","first-page":"485","article-title":"Miscellanea: Peyronie\u2019s disease (fibrous cavernositis)","author":"Murphy","year":"1972"},{"key":"10.1016\/j.ucl.2013.07.003_bib105","first-page":"350","article-title":"Peyronie\u2019s disease (plastic induration) cause and treatment","volume":"49","author":"Wesson","year":"1943","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ucl.2013.07.003_bib106","series-title":"A\u00a0treatise on the venereal disease","first-page":"88","article-title":"Of the treatment of occasional symptoms of the gonorrhea","author":"Hunter","year":"1818"},{"key":"10.1016\/j.ucl.2013.07.003_bib107","series-title":"The consequences of gonorrhea. Lecture on anatomy, surgery, and pathology: including observations on the nature and treatment of local diseases, delivered at St. Bartholomew\u2019s and Christ\u2019s Hospitals","first-page":"205","author":"Abernethy","year":"1828"},{"issue":"4","key":"10.1016\/j.ucl.2013.07.003_bib108","first-page":"1395","article-title":"Treatment of Peyronie\u2019s disease with intralesional verapamil injection","volume":"158","author":"Levine","year":"1997","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.ucl.2013.07.003_bib109","first-page":"285","article-title":"Proposal: trauma as the cause of the Peyronie\u2019s lesion","volume":"157","author":"Devine","year":"1997","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.ucl.2013.07.003_bib110","first-page":"186","article-title":"Trauma as the cause of Peyronie\u2019s disease: penile fracture as a model of trauma","volume":"172","author":"Zargooshi","year":"2004","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ucl.2013.07.003_bib111","unstructured":"Cole A. Increased endogenous inhibitors of collagenases within Peyronie\u2019s plaques may represent a scar remodeling disorder [abstract 944]. Annual Meeting of the American Urological Association. San Antonio, May 21\u201326, 2005."},{"key":"10.1016\/j.ucl.2013.07.003_bib112","first-page":"287","article-title":"ID induratio penis plastica","volume":"32","author":"Polkey","year":"1928","journal-title":"Urol Cut Rev"},{"key":"10.1016\/j.ucl.2013.07.003_bib113","first-page":"319","article-title":"Die Radiumbehandlung der induratio penis plastica","volume":"61","author":"Ludvik","year":"1968","journal-title":"Z\u00a0Urol Nephrol"},{"key":"10.1016\/j.ucl.2013.07.003_bib114","first-page":"272","article-title":"Introduction to Peyronie\u2019s disease","volume":"157","author":"Devine","year":"1997","journal-title":"J\u00a0Urol"},{"issue":"4","key":"10.1016\/j.ucl.2013.07.003_bib115","first-page":"1007","article-title":"The incidence of Peyronie\u2019s disease in Rochester, Minnesota, 1950 through 1984","volume":"146","author":"Lindsay","year":"1991","journal-title":"J\u00a0Urol"},{"issue":"6 Pt 1","key":"10.1016\/j.ucl.2013.07.003_bib116","first-page":"2350","article-title":"Subjective and objective analysis of the prevalence of Peyronie\u2019s disease in a population of men presenting for prostate cancer screening","volume":"171","author":"Mulhall","year":"2004","journal-title":"J\u00a0Urol"},{"issue":"6","key":"10.1016\/j.ucl.2013.07.003_bib117","first-page":"1376","article-title":"The natural history of Peyronie\u2019s disease","volume":"144","author":"Gelbard","year":"1990","journal-title":"J\u00a0Urol"},{"issue":"3","key":"10.1016\/j.ucl.2013.07.003_bib118","first-page":"1075","article-title":"A\u00a0retrospective review of 307 men with Peyronie\u2019s disease","volume":"168","author":"Kadioglu","year":"2002","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ucl.2013.07.003_bib119","unstructured":"Mulhall JP, Guhring P, Depierro C. Intralesional verapamil prevents progression of Peyronie\u2019s disease [abstract 936]. Annual Meeting of the American Urological Association. San Antonio, May 21\u201326, 2005."},{"issue":"1","key":"10.1016\/j.ucl.2013.07.003_bib120","first-page":"27","article-title":"Peyronie\u2019s disease in younger men: characteristics and treatment results","volume":"24","author":"Levine","year":"2003","journal-title":"J\u00a0Androl"},{"issue":"1","key":"10.1016\/j.ucl.2013.07.003_bib121","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/sj.ijir.3900635","article-title":"Peyronie\u2019s disease in men under 40: characteristics and outcome","volume":"13","author":"Tefekli","year":"2001","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.ucl.2013.07.003_bib122","first-page":"485","article-title":"Defining the clinical characteristics of Peyronie\u2019s disease in young men","volume":"4","author":"Deveci","year":"2007","journal-title":"J\u00a0Sex Med"},{"issue":"1","key":"10.1016\/j.ucl.2013.07.003_bib123","first-page":"69","article-title":"Peyronie\u2019s disease: a study of its natural history and treatment with orthovoltage radiotherapy","volume":"114","author":"Furlow","year":"1975","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ucl.2013.07.003_bib124","first-page":"1075","article-title":"A\u00a0retrospective review of 307 men with Peyronie\u2019s disease","volume":"168","author":"Deveci","year":"2002","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.ucl.2013.07.003_bib125","first-page":"75","article-title":"The natural history of Peyronie\u2019s disease","volume":"103","author":"Williams","year":"1970","journal-title":"J\u00a0Urol"},{"issue":"Suppl 5","key":"10.1016\/j.ucl.2013.07.003_bib126","first-page":"202","article-title":"Lessons learned from 307 men with Peyronie\u2019s disease","volume":"165","author":"Kadioglu","year":"2001","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ucl.2013.07.003_bib127","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00007611-194802000-00017","article-title":"A\u00a0new concept in the treatment of Peyronie\u2019s disease","volume":"41","author":"Scott","year":"1948","journal-title":"South Med J"},{"key":"10.1016\/j.ucl.2013.07.003_bib128","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/sj.ijir.3900880","article-title":"Role of oxidative stress and antioxidants in Peyronie\u2019s disease","volume":"14","author":"Sikka","year":"2002","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.ucl.2013.07.003_bib129","first-page":"41","article-title":"Controlled clinical trial of vitamin E in Peyronie\u2019s disease","volume":"9","author":"Pryor","year":"1983","journal-title":"Progress in Reproductive Biology and Medicine"},{"issue":"4 Pt 1","key":"10.1016\/j.ucl.2013.07.003_bib130","first-page":"1398","article-title":"Comparison of vitamin E and propionyl-L-carnitine, separately or in combination, in patients with early chronic Peyronie\u2019s disease: a double-blind, placebo controlled, randomized study","volume":"178","author":"Safarinejad","year":"2007","journal-title":"J\u00a0Urol"},{"issue":"22","key":"10.1016\/j.ucl.2013.07.003_bib131","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1056\/NEJMoa011090","article-title":"Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease","volume":"345","author":"Brown","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ucl.2013.07.003_bib132","series-title":"Basic and clinical pharmacology","article-title":"Nonsteroidal anti-inflammatory drugs, disease-modifying antirheumatic drugs, nonopioid analgesics & drugs used in gout","author":"Furst","year":"2001"},{"issue":"2","key":"10.1016\/j.ucl.2013.07.003_bib133","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0090-4295(94)80155-X","article-title":"Is colchicine effective in Peyronie\u2019s disease? A pilot study","volume":"44","author":"Akkus","year":"1994","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.ucl.2013.07.003_bib134","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/sj.ijir.3900519","article-title":"Treatment of Peyronie\u2019s disease with oral colchicine: long-term results and predictive parameters of successful outcome","volume":"12","author":"Kadioglu","year":"2000","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.ucl.2013.07.003_bib135","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/sj.ijir.3901185","article-title":"Therapeutic effects of colchicine in the management of Peyronie\u2019s disease: a randomized double-blind, placebo-controlled study","volume":"16","author":"Safarinejad","year":"2004","journal-title":"Int J Impot Res"},{"issue":"6","key":"10.1016\/j.ucl.2013.07.003_bib136","first-page":"770","article-title":"Treatment of Peyronie\u2019s disease with potassium para-aminobenzoate (potaba)","volume":"81","author":"Zarafonetis","year":"1959","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.ucl.2013.07.003_bib137","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2340\/00015555721518","article-title":"A\u00a0comparison of morphoea and lichen sclerosus et atrophicus in\u00a0vitro: the effects of para-aminobenzoate on skin fibroblasts","volume":"72","author":"Griffiths","year":"1992","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"10.1016\/j.ucl.2013.07.003_bib138","first-page":"224","article-title":"Treatment of Peyronie\u2019s disease with para-aminobenzoacidic potassium (POTOBA) (author\u2019s transl)","volume":"17","author":"Hasche-Klunder","year":"1978","journal-title":"Urologe A"},{"issue":"Suppl 4","key":"10.1016\/j.ucl.2013.07.003_bib139","first-page":"205","article-title":"Randomized prospective placebo-controlled therapy of Peyronie\u2019s disease (IPP) with Potaba* (aminobenzoate potassium)","volume":"6","author":"Weidner","year":"1999","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ucl.2013.07.003_bib140","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.eururo.2004.12.022","article-title":"Potassium paraaminobenzoate (Potaba) in the treatment of Peyronie\u2019s disease: a prospective, placebo controlled, randomized study","volume":"47","author":"Weidner","year":"2005","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.ucl.2013.07.003_bib141","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1464-410X.1992.tb15836.x","article-title":"The treatment of Peyronie\u2019s disease with tamoxifen","volume":"70","author":"Ralph","year":"1992","journal-title":"Br J Urol"},{"issue":"3","key":"10.1016\/j.ucl.2013.07.003_bib142","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/bjc.1990.307","article-title":"Anti-oestrogens\u00a0induce the secretion of active transforming growth factor beta from human fetal fibroblasts","volume":"62","author":"Colletta","year":"1990","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.ucl.2013.07.003_bib143","first-page":"2003","article-title":"Tamoxifen versus placebo in the treatment of Peyronie\u2019s disease","volume":"162","author":"Teloken","year":"1999","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.ucl.2013.07.003_bib144","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1464-410x.2001.02241.x","article-title":"Acetyl-L-carnitine vs tamoxifen in the oral therapy of Peyronie\u2019s disease: a preliminary report","volume":"88","author":"Biagiotti","year":"2001","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.ucl.2013.07.003_bib145","first-page":"2077","article-title":"Pentoxifylline attenuates transforming growth factor-b1-stimulated collagen deposition and elastogenesis in human tunica albuginea-derived fibroblasts part 1: impact on extracellular matrix","volume":"7","author":"Shindel","year":"2010","journal-title":"J\u00a0Sex Med"},{"issue":"5","key":"10.1016\/j.ucl.2013.07.003_bib146","first-page":"1787","article-title":"Pentoxifylline attenuates transforming growth factor-beta1-stimulated elastogenesis in human tunica albuginea-derived fibroblasts part 2: interference in a TGF-beta1\/Smad-dependent mechanism and downregulation of AAT1","volume":"7","author":"Lin","year":"2010","journal-title":"J\u00a0Sex Med"},{"issue":"2","key":"10.1016\/j.ucl.2013.07.003_bib147","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1464-410X.2009.09041.x","article-title":"A\u00a0double-blind placebo-controlled study of the efficacy and safety of pentoxifylline in early chronic Peyronie\u2019s disease","volume":"106","author":"Safarinejad","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.ucl.2013.07.003_bib148","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0090-4295(98)00582-2","article-title":"EDITS: development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction","volume":"53","author":"Althof","year":"1999","journal-title":"Urology"},{"issue":"7","key":"10.1016\/j.ucl.2013.07.003_bib149","first-page":"2359","article-title":"The management of Peyronie\u2019s disease: evidence based 2010 guidelines","volume":"7","author":"Ralph","year":"2010","journal-title":"J\u00a0Sex Med"},{"issue":"4721","key":"10.1016\/j.ucl.2013.07.003_bib150","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1126\/science.2994224","article-title":"Pathways of protein secretion in eukaryotes","volume":"230","author":"Kelly","year":"1985","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.ucl.2013.07.003_bib151","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1083\/jcb.98.5.1662","article-title":"Changes in cell shape correlate with collagenase gene expression in rabbit synovial fibroblasts","volume":"98","author":"Aggeler","year":"1984","journal-title":"J\u00a0Cell Biol"},{"issue":"5","key":"10.1016\/j.ucl.2013.07.003_bib152","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0022-4804(90)90197-A","article-title":"Calcium antagonists retard extracellular matrix production in connective tissue equivalent","volume":"49","author":"Lee","year":"1990","journal-title":"J\u00a0Surg Res"},{"issue":"6","key":"10.1016\/j.ucl.2013.07.003_bib153","first-page":"2483","article-title":"Transdermal application of verapamil gel to the penile shaft fails to infiltrate the tunica albuginea","volume":"168","author":"Martin","year":"2002","journal-title":"J\u00a0Urol"},{"issue":"5","key":"10.1016\/j.ucl.2013.07.003_bib154","first-page":"611","article-title":"Peyronie\u2019s disease a new approach","volume":"71","author":"Teasley","year":"1954","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ucl.2013.07.003_bib155","first-page":"400","article-title":"Peyronie\u2019s disease: cortisone-hyaluronidase-hydrocortisone therapy","volume":"72","author":"Bodner","year":"1954","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ucl.2013.07.003_bib156","first-page":"898","article-title":"Peyronie\u2019s disease: results with dermo-jet injection of dexamethasone","volume":"14","author":"Winter","year":"1975","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ucl.2013.07.003_bib157","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1464-410X.1980.tb03067.x","article-title":"The non-surgical treatment of Peyronie\u2019s disease","volume":"52","author":"Williams","year":"1980","journal-title":"Br J Urol"},{"key":"10.1016\/j.ucl.2013.07.003_bib158","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF00255956","article-title":"Collagenase for Peyronie\u2019s disease: experimental studies","volume":"10","author":"Gelbard","year":"1982","journal-title":"Urol Res"},{"key":"10.1016\/j.ucl.2013.07.003_bib159","first-page":"280","article-title":"The use of collagenase in the treatment of Peyronie\u2019s disease","volume":"134","author":"Gelbard","year":"1985","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.ucl.2013.07.003_bib160","first-page":"56","article-title":"Collagenase versus placebo in the treatment of Peyronie\u2019s disease: a double-blind study","volume":"149","author":"Gelbard","year":"1993","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.ucl.2013.07.003_bib161","first-page":"180","article-title":"The use of intralesional clostridial collagenase injection therapy for Peyronie\u2019s disease: a prospective, single-center, non-placebo-controlled study","volume":"5","author":"Jordan","year":"2008","journal-title":"J\u00a0Sex Med"},{"issue":"6","key":"10.1016\/j.ucl.2013.07.003_bib162","first-page":"1522","article-title":"Intralesional verapamil injection for the treatment of Peyronie\u2019s disease","volume":"151","author":"Levine","year":"1994","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.ucl.2013.07.003_bib163","first-page":"621","article-title":"Experience with intraplaque injection of verapamil for Peyronie\u2019s disease","volume":"168","author":"Levine","year":"2002","journal-title":"J\u00a0Urol"},{"issue":"6","key":"10.1016\/j.ucl.2013.07.003_bib164","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.urology.2007.02.042","article-title":"Intralesional verapamil prevents the progression of Peyronie\u2019s disease","volume":"69","author":"Bennett","year":"2007","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.ucl.2013.07.003_bib165","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0090-4295(97)00700-0","article-title":"Use of intralesional verapamil to dissolve Peyronie\u2019s disease plaque: a longterm single-blind study","volume":"51","author":"Rehman","year":"1998","journal-title":"Urology"},{"issue":"11","key":"10.1016\/j.ucl.2013.07.003_bib166","first-page":"3743","article-title":"Nicardipine vs. saline injection as treatment for Peyronie\u2019s disease: a prospective, randomized, single-blind trial","volume":"7","author":"Soh","year":"2010","journal-title":"J\u00a0Sex Med"},{"issue":"3","key":"10.1016\/j.ucl.2013.07.003_bib167","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11255-009-9522-4","article-title":"Effect of intralesional verapamil for treatment of Peyronie\u2019s disease: a randomized single-blind, placebo controlled study","volume":"41","author":"Shirazi","year":"2009","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"10.1016\/j.ucl.2013.07.003_bib168","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/00365599109024539","article-title":"Regulation of the proliferation and biosynthetic activities of cultured human Peyronie\u2019s disease fibroblasts by interferons-alpha, -beta and -gamma","volume":"25","author":"Duncan","year":"1991","journal-title":"Scand J Urol Nephrol"},{"issue":"3","key":"10.1016\/j.ucl.2013.07.003_bib169","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1159\/000475057","article-title":"Treatment of Peyronie\u2019s disease with local interferon alpha 2b","volume":"28","author":"Wegner","year":"1995","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.ucl.2013.07.003_bib170","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000480857","article-title":"Local interferon-alpha 2b is not an effective treatment in early-stage Peyronie\u2019s disease","volume":"32","author":"Wegner","year":"1997","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.ucl.2013.07.003_bib171","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1046\/j.1464-410X.1997.02849.x","article-title":"Intralesional interferon in the treatment of Peyronie\u2019s disease: a pilot study","volume":"79","author":"Judge","year":"1997","journal-title":"Br J Urol"},{"issue":"4","key":"10.1016\/j.ucl.2013.07.003_bib172","first-page":"444","article-title":"A\u00a0pilot study demonstrating clinical benefit from intralesional interferon alpha 2B in the treatment of Peyronie\u2019s disease","volume":"20","author":"Ahuja","year":"1999","journal-title":"J\u00a0Androl"},{"issue":"1","key":"10.1016\/j.ucl.2013.07.003_bib173","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/01.SMJ.0000056658.60032.D3","article-title":"Intralesional interferon-alpha-2B injections for the treatment of Peyronie\u2019s disease","volume":"97","author":"Dang","year":"2004","journal-title":"South Med J"},{"key":"10.1016\/j.ucl.2013.07.003_bib174","first-page":"394","article-title":"Singleblind, multicenter placebo controlled parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie\u2019s disease","volume":"176","author":"Hellstrom","year":"2006","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ucl.2013.07.003_bib175","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.urology.2005.11.005","article-title":"Effect of intralesional interferon-alpha 2b combined with oral vitamin E for treatment of early stage Peyronie\u2019s disease: a randomized and prospective study","volume":"67","author":"Inal","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.ucl.2013.07.003_bib176","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1038\/sj.ijir.3901084","article-title":"Review of current nonsurgical management of Peyronie\u2019s disease","volume":"15","author":"Levine","year":"2003","journal-title":"Int J Impot Res"},{"issue":"5","key":"10.1016\/j.ucl.2013.07.003_bib177","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0090-4295(02)01970-2","article-title":"Evaluation of extracorporeal shock wave therapy in Peyronie\u2019s disease","volume":"60","author":"Manikandan","year":"2002","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.ucl.2013.07.003_bib178","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0090-4295(02)01527-3","article-title":"Extracorporeal shock wave therapy in the treatment of Peyronie\u2019s disease: experience with standard lithotriptor (siemens-multiline)","volume":"59","author":"Lebret","year":"2002","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.ucl.2013.07.003_bib179","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.eururo.2009.05.012","article-title":"A\u00a0first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie\u2019s disease","volume":"56","author":"Palmieri","year":"2009","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.ucl.2013.07.003_bib180","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1159\/000020359","article-title":"Extracorporeal shock wave therapy in the treatment of Peyronie\u2019s disease. First results of a case-controlled approach","volume":"38","author":"Hauck","year":"2000","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.ucl.2013.07.003_bib181","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1001\/archderm.1990.01670260092018","article-title":"Electrical stimulation and wound healing","volume":"126","author":"Weiss","year":"1990","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.ucl.2013.07.003_bib182","first-page":"1775","article-title":"Tunica albuginea tissue analysis after electromotive drug administration","volume":"169","author":"Levine","year":"2003","journal-title":"J\u00a0Urol"},{"issue":"3","key":"10.1016\/j.ucl.2013.07.003_bib183","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.urology.2009.03.017","article-title":"Effect of transdermal electromotive drug therapy on fibrogenic cytokine expression in Peyronie\u2019s disease","volume":"74","author":"Stancik","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.ucl.2013.07.003_bib184","first-page":"972","article-title":"Verapamil versus saline in electromotive drug administration (EDMA) for Peyronie\u2019s disease: a double blind, placebo controlled trial","volume":"177","author":"Greenfield","year":"2007","journal-title":"J\u00a0Urol"},{"issue":"9","key":"10.1016\/j.ucl.2013.07.003_bib185","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1046\/j.1464-410X.2003.04242.x","article-title":"Transdermal electromotive administration of verapamil and dexamethasone for Peyronie\u2019s disease","volume":"91","author":"Di Stasi","year":"2003","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.ucl.2013.07.003_bib186","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1046\/j.1464-410X.2003.04134.x","article-title":"Combined treatment with vitamin E and colchicine in the early stages of Peyronie\u2019s disease","volume":"91","author":"Prieto Castro","year":"2003","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.ucl.2013.07.003_bib187","first-page":"384","article-title":"Ultrasound- guided ESWT in Peyronie\u2019s disease plaques","volume":"72","author":"Mirone","year":"2000","journal-title":"Arch Ital Urol Androl"},{"issue":"4","key":"10.1016\/j.ucl.2013.07.003_bib188","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000020013","article-title":"Our experience on the association of a new physical and medical therapy in patients suffering from induratio penis plastica","volume":"36","author":"Mirone","year":"1999","journal-title":"Eur Urol"},{"issue":"9","key":"10.1016\/j.ucl.2013.07.003_bib189","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1046\/j.1464-410X.2002.02738.x","article-title":"Oral propionyl-l-carnitine and intraplaque verapamil in the therapy of advanced and resistant Peyronie\u2019s disease","volume":"89","author":"Cavallini","year":"2002","journal-title":"BJU Int"},{"issue":"119","key":"10.1016\/j.ucl.2013.07.003_bib190","doi-asserted-by":"crossref","first-page":"PE6","DOI":"10.1126\/stke.2002.119.pe6","article-title":"Mechanotransduction: all signals point to cytoskeleton, matrix, and integrins","volume":"2002","author":"Alenghat","year":"2002","journal-title":"Sci STKE"},{"issue":"3","key":"10.1016\/j.ucl.2013.07.003_bib191","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1054\/bjps.1997.3044","article-title":"Progressive skin extension: clinical and histological evaluation of a modified procedure using Kirschner wires","volume":"52","author":"Molea","year":"1999","journal-title":"Br J Plast Surg"},{"key":"10.1016\/j.ucl.2013.07.003_bib192","doi-asserted-by":"crossref","first-page":"53","DOI":"10.22203\/eCM.v015a05","article-title":"Bone development and its relation to fracture repair. The role of mesenchymal osteoblasts and surface osteoblasts","volume":"15","author":"Shapiro","year":"2008","journal-title":"Eur Cell Mater"},{"issue":"5","key":"10.1016\/j.ucl.2013.07.003_bib193","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1097\/01.prs.0000182345.86453.4f","article-title":"Microarray analysis of mechanical shear effects on flexor tendon cells","volume":"116","author":"Fong","year":"2005","journal-title":"Plast Reconstr Surg"},{"issue":"3","key":"10.1016\/j.ucl.2013.07.003_bib194","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1586\/17434440.5.3.305","article-title":"FastSize Medical Extender for the treatment of Peyronie\u2019s disease","volume":"5","author":"Levine","year":"2008","journal-title":"Expert Rev Med Devices"},{"issue":"2","key":"10.1016\/j.ucl.2013.07.003_bib195","first-page":"558","article-title":"Use of penile extender device in the treatment of penile curvature as a result of Peyronie\u2019s disease. Results of a phase II prospective study","volume":"6","author":"Gontero","year":"2009","journal-title":"J\u00a0Sex Med"},{"issue":"pii","key":"10.1016\/j.ucl.2013.07.003_bib196","first-page":"37","article-title":"Penile traction therapy in Peyronie\u2019s disease","volume":"1","author":"Greenfield","year":"2009","journal-title":"F1000 Med Rep"},{"issue":"Suppl 5","key":"10.1016\/j.ucl.2013.07.003_bib197","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1038\/sj.ijir.3901083","article-title":"Establishing a standardized evaluation of the man with Peyronie\u2019s disease","volume":"15","author":"Levine","year":"2003","journal-title":"Int J Impot Res"}],"container-title":["Urologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014313000645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014313000645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:25:04Z","timestamp":1758806704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0094014313000645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":197,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0094014313000645"],"URL":"https:\/\/doi.org\/10.1016\/j.ucl.2013.07.003","relation":{},"ISSN":["0094-0143"],"issn-type":[{"type":"print","value":"0094-0143"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Office-Based Management of Impotence and Peyronie\u2019s Disease","name":"articletitle","label":"Article Title"},{"value":"Urologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ucl.2013.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}